{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:39:23Z","timestamp":1792474763461,"version":"4.5.0"},"reference-count":174,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancertreatmentreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ctrv.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T12:03:44Z","timestamp":1424261024000},"page":"310-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["A contemporary review of management and prognostic factors of upper tract urothelial carcinoma"],"prefix":"10.1016","volume":"41","author":[{"given":"Jeffrey J.","family":"Leow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Orsola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Bellmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0005","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","article-title":"European guidelines on upper tract urothelial carcinomas: 2013 update","volume":"63","author":"Roupret","year":"2013","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0010","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1464-410X.2006.06524.x","article-title":"Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?","volume":"98","author":"Brown","year":"2006","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.eururo.2012.04.052","article-title":"Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma","volume":"65","author":"Xylinas","year":"2014","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0020","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.eururo.2009.12.032","article-title":"Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma","volume":"57","author":"Li","year":"2010","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1464-410X.2010.09826.x","article-title":"Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort","volume":"108","author":"Walton","year":"2011","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0030","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.eururo.2007.04.070","article-title":"Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival","volume":"52","author":"Brausi","year":"2007","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0035","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.eururo.2009.06.004","article-title":"The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?","volume":"56","author":"Roscigno","year":"2009","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0040","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.eururo.2011.07.009","article-title":"Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer","volume":"60","author":"Roscigno","year":"2011","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0045","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.eururo.2010.03.025","article-title":"Words of wisdom. Re: laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study","volume":"57","author":"Greco","year":"2010","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2009.06.013","article-title":"Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study","volume":"56","author":"Simone","year":"2009","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0055","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.eururo.2012.02.019","article-title":"Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies","volume":"61","author":"Ni","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eururo.2009.03.072","article-title":"Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases","volume":"56","author":"Capitanio","year":"2009","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0065","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.eururo.2010.08.005","article-title":"Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?","volume":"58","author":"Favaretto","year":"2010","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0070","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.eururo.2004.08.006","article-title":"Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery?","volume":"46","author":"Rassweiler","year":"2004","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.ctrv.2015.02.006_b0075","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/end.2011.0223","article-title":"Long-term comparative outcomes of open versus laparoscopic nephroureterectomy for upper urinary tract urothelial-cell carcinoma after a median follow-up of 13years\u2217","volume":"25","author":"Stewart","year":"2011","journal-title":"J Endourol"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0080","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.eururo.2011.12.026","article-title":"Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series","volume":"61","author":"Hanna","year":"2012","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11934-012-0303-8","article-title":"Current status of robot assisted laparoscopic radical nephroureterectomy for management of upper tract urothelial carcinoma","volume":"14","author":"Lim","year":"2013","journal-title":"Curr Urol Rep"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0090","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/j.juro.2014.02.682","article-title":"Propensity matched comparison of morbidity and costs of open vs. minimally invasive radical nephroureterectomy: a contemporary population-based analysis in the United States","volume":"191","author":"Leow","year":"2014","journal-title":"J Urol"},{"issue":"9\u201310","key":"10.1016\/j.ctrv.2015.02.006_b0095","doi-asserted-by":"crossref","first-page":"E695","DOI":"10.5489\/cuaj.2051","article-title":"Robot-assisted versus laparoscopic nephroureterectomy for upper-tract urothelial cancer: a population-based assessment of costs and perioperative outcomes","volume":"8","author":"Trudeau","year":"2014","journal-title":"Can Urol Assoc J"},{"issue":"12","key":"10.1016\/j.ctrv.2015.02.006_b0100","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.ejso.2014.06.007","article-title":"Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies","volume":"40","author":"Yakoubi","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","article-title":"Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature","volume":"62","author":"Lughezzani","year":"2012","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0110","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.eururo.2006.11.021","article-title":"Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival","volume":"51","author":"Lehmann","year":"2007","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0115","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.eururo.2008.01.054","article-title":"Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients","volume":"54","author":"Li","year":"2008","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0120","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0125","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","article-title":"Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study","volume":"57","author":"Novara","year":"2010","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0130","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.eururo.2011.05.049","article-title":"Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy","volume":"60","author":"Ouzzane","year":"2011","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.ctrv.2015.02.006_b0135","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1245\/s10434-012-2453-9","article-title":"Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival","volume":"19","author":"Colin","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2009.11.035","article-title":"Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract","volume":"57","author":"Zigeuner","year":"2010","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.ctrv.2015.02.006_b0145","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ejca.2013.02.001","article-title":"Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy","volume":"49","author":"Xylinas","year":"2013","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/modpathol.2012.139","article-title":"Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract","volume":"26","author":"Kitamura","year":"2013","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0155","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.urology.2008.07.042","article-title":"Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study","volume":"73","author":"Fernandez","year":"2009","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00345-010-0594-7","article-title":"Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma","volume":"29","author":"Shariat","year":"2011","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0165","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.urology.2009.09.048","article-title":"Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database","volume":"75","author":"Lughezzani","year":"2010","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.ctrv.2015.02.006_b0170","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"issue":"8","key":"10.1016\/j.ctrv.2015.02.006_b0175","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1464-410X.2011.10479.x","article-title":"Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study","volume":"109","author":"Martinez-Salamanca","year":"2012","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.juro.2011.03.031","article-title":"Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma","volume":"186","author":"Ehdaie","year":"2011","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0185","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1464-410X.2012.11260.x","article-title":"Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma","volume":"111","author":"Ehdaie","year":"2013","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0190","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s11255-011-9915-z","article-title":"Prognostic factors for upper urinary tract urothelial carcinomas: stage, grade, and smoking status","volume":"43","author":"Simsir","year":"2011","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0195","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.juro.2010.12.035","article-title":"Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma","volume":"185","author":"Ito","year":"2011","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.eururo.2011.09.017","article-title":"The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy","volume":"61","author":"Chromecki","year":"2012","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0205","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1464-410X.2012.11353.x","article-title":"Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma","volume":"111","author":"Tanaka","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.ctrv.2015.02.006_b0210","doi-asserted-by":"crossref","DOI":"10.1111\/bju.12631","article-title":"Post-operative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localized and\/or locally advanced upper tract urothelial carcinoma without metastasis","author":"Seisen","year":"2014","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0215","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.juro.2010.03.142","article-title":"Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract","volume":"184","author":"Margulis","year":"2010","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2011.10288.x","article-title":"Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma","volume":"109","author":"Favaretto","year":"2012","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00345-012-0947-5","article-title":"Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma","volume":"31","author":"Xylinas","year":"2013","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0230","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1148\/rg.256045517","article-title":"Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings","volume":"25","author":"Browne","year":"2005","journal-title":"Radiographics"},{"issue":"10","key":"10.1016\/j.ctrv.2015.02.006_b0235","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11604-013-0237-1","article-title":"Diffusion-weighted MRI of renal cell carcinoma, upper tract urothelial carcinoma, and renal infection: a pictorial review","volume":"31","author":"Cogley","year":"2013","journal-title":"Jpn J Radiol"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0240","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.juro.2006.04.018","article-title":"Contribution of 11C-choline positron emission tomography\/computerized tomography to preoperative staging of advanced transitional cell carcinoma","volume":"176","author":"Gofrit","year":"2006","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0245","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.eururo.2006.09.042","article-title":"Re: contribution of 11C-choline positron emission tomography\/computerized tomography to preoperative staging of advance transitional cell carcinoma","volume":"51","author":"Steinberg","year":"2007","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0250","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.juro.2009.05.011","article-title":"Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the upper tract urothelial carcinoma collaboration","volume":"182","author":"Hellenthal","year":"2009","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0255","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00345-011-0775-z","article-title":"The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study","volume":"30","author":"Kawashima","year":"2012","journal-title":"World J Urol"},{"issue":"8","key":"10.1016\/j.ctrv.2015.02.006_b0260","doi-asserted-by":"crossref","first-page":"686","DOI":"10.7150\/jca.7326","article-title":"The efficacy of adjuvant chemotherapy for locally advanced upper tract urothelial cell carcinoma","volume":"4","author":"Kim","year":"2013","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0265","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.urology.2006.01.053","article-title":"Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract","volume":"68","author":"Kwak","year":"2006","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0270","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000092930","article-title":"Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract","volume":"77","author":"Lee","year":"2006","journal-title":"Urol Int"},{"issue":"9","key":"10.1016\/j.ctrv.2015.02.006_b0275","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1442-2042.2008.02114.x","article-title":"Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma","volume":"15","author":"Soga","year":"2008","journal-title":"Int J Urol"},{"issue":"7","key":"10.1016\/j.ctrv.2015.02.006_b0280","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1442-2042.2004.00841.x","article-title":"Impact of adjuvant systemic chemotherapy on postoperative survival in patients with high-risk urothelial cancer","volume":"11","author":"Suzuki","year":"2004","journal-title":"Int J Urol"},{"issue":"24","key":"10.1016\/j.ctrv.2015.02.006_b0285","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1002\/cncr.26172","article-title":"Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study","volume":"117","author":"Vassilakopoulou","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0290","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.urolonc.2012.11.014","article-title":"Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome","volume":"32","author":"Yafi","year":"2014","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0295","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0300","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","article-title":"An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer","volume":"56","author":"Malmstrom","year":"2009","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0305","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.eururo.2011.07.051","article-title":"Antegrade perfusion with bacillus Calmette\u2013Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?","volume":"60","author":"Giannarini","year":"2011","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0310","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0090-4295(01)01488-1","article-title":"Intravesical instillation of bacille Calmette\u2013Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter","volume":"59","author":"Irie","year":"2002","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0315","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.urology.2004.01.046","article-title":"Long-term effects of bacille Calmette\u2013Guerin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract","volume":"63","author":"Hayashida","year":"2004","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0320","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","article-title":"Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)","volume":"60","author":"O\u2019Brien","year":"2011","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0325","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.eururo.2011.11.026","volume":"61","author":"Remzi","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2015.02.006_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2014.11.035","article-title":"A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma","author":"Seisen","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2015.02.006_b0335","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1471-2407-11-297","article-title":"Radiotherapy may improve overall survival of patients with T3\/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Cancer"},{"issue":"3 Pt 1","key":"10.1016\/j.ctrv.2015.02.006_b0340","first-page":"703","article-title":"Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy","volume":"160","author":"Hall","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.ctrv.2015.02.006_b0345","series-title":"Perez & Brady\u2019s principles and practice of radiation oncology, 6e","article-title":"Chapter 63: cancer of the kidney, renal pelvis, and ureter","author":"Gay","year":"2013"},{"issue":"4 Pt 1","key":"10.1016\/j.ctrv.2015.02.006_b0350","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ju.0000137910.38441.8a","article-title":",Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter","volume":"172","author":"Czito","year":"2004","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0355","first-page":"247","article-title":"Adjuvant and salvage radiotherapy for urothelial cell carcinoma of the upper urinary tract: experience in a single institution","volume":"35","author":"Fan","year":"2012","journal-title":"Chang Gung Med J"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0360","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0360-3016(92)90723-U","article-title":"Adjuvant radiotherapy in high stage transitional cell carcinoma of the renal pelvis and ureter","volume":"24","author":"Cozad","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0365","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-5347(01)66563-7","article-title":"Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?","volume":"155","author":"Maulard-Durdux","year":"1996","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0370","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000343729","article-title":"Patterns of failure and prognostic factors for locoregional recurrence after radical surgery in upper urinary tract transitional cell carcinoma: implications for adjuvant radiotherapy","volume":"90","author":"Jang","year":"2013","journal-title":"Urol Int"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0375","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1078155210394695","article-title":"Newer developments in the therapeutics of the transitional cell carcinoma of renal pelvis","volume":"18","author":"Dasanu","year":"2012","journal-title":"J Oncol Pharm Pract"},{"issue":"10","key":"10.1016\/j.ctrv.2015.02.006_b0380","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nrclinonc.2013.155","article-title":"Molecular targets on the horizon for kidney and urothelial cancer","volume":"10","author":"Bellmunt","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0385","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4155\/cli.11.26","article-title":"Personalized therapy for urothelial cancer: review of the clinical evidence","volume":"1","author":"Guancial","year":"2011","journal-title":"Clin Investig (Lond)"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0390","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0395","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.eururo.2012.09.057","article-title":"ICUD-EAU international consultation on bladder cancer 2012: screening, diagnosis, and molecular markers","volume":"63","author":"Kamat","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2015.02.006_b0400","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","author":"The Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"issue":"Suppl. 4","key":"10.1016\/j.ctrv.2015.02.006_b0405","article-title":"Targeted sequencing of upper tract urothelial carcinoma","volume":"32","author":"Sfakianos","year":"2014","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0410","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.juro.2009.05.040","article-title":"The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival","volume":"182","author":"Park","year":"2009","journal-title":"J Urol"},{"issue":"18","key":"10.1016\/j.ctrv.2015.02.006_b0415","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1016\/j.ejca.2009.06.016","article-title":"Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients","volume":"45","author":"Lughezzani","year":"2009","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0420","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.juro.2009.07.035","article-title":"Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma","volume":"182","author":"Isbarn","year":"2009","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0425","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-5347(06)00511-8","article-title":"Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma","volume":"176","author":"Akdogan","year":"2006","journal-title":"J Urol"},{"issue":"2 Pt 1","key":"10.1016\/j.ctrv.2015.02.006_b0430","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000107767.56680.f7","article-title":"The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract","volume":"171","author":"Park","year":"2004","journal-title":"J Urol"},{"issue":"6 Pt 1","key":"10.1016\/j.ctrv.2015.02.006_b0435","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1097\/01.ju.0000144505.40915.98","article-title":"Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma","volume":"172","author":"Mullerad","year":"2004","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.ctrv.2015.02.006_b0440","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/cncr.22970","article-title":"Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers","volume":"110","author":"Novara","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0445","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.juro.2009.04.026","article-title":"The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy","volume":"182","author":"Li","year":"2009","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0450","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/modpathol.3800529","article-title":"pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract","volume":"19","author":"Langner","year":"2006","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0455","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1200\/JCO.2001.19.1.94","article-title":"Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance","volume":"19","author":"Rabbani","year":"2001","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0460","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.eururo.2009.03.003","article-title":"Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan","volume":"55","author":"Kamihira","year":"2009","journal-title":"Eur Urol"},{"issue":"13","key":"10.1016\/j.ctrv.2015.02.006_b0465","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/cncr.24339","article-title":"Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality","volume":"115","author":"Inman","year":"2009","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0470","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.juro.2009.02.021","article-title":"Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"181","author":"Roscigno","year":"2009","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0475","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.urology.2009.07.1296","article-title":"A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma","volume":"75","author":"Lughezzani","year":"2010","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0480","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1464-410X.2008.07988.x","article-title":"Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density","volume":"103","author":"Bolenz","year":"2009","journal-title":"BJU Int"},{"issue":"9","key":"10.1016\/j.ctrv.2015.02.006_b0485","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1464-410X.2010.09341.x","article-title":"Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma","volume":"106","author":"Pieras","year":"2010","journal-title":"BJU Int"},{"issue":"8","key":"10.1016\/j.ctrv.2015.02.006_b0490","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1464-410X.2008.08134.x","article-title":"Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma","volume":"103","author":"Simone","year":"2009","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0495","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2008.17.2361","article-title":"Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma","volume":"27","author":"Kikuchi","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0500","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.juro.2006.04.019","article-title":"Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract","volume":"176","author":"Langner","year":"2006","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0505","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jjco\/hyl123","article-title":"Prognostic significance of tumor necrosis in primary transitional cell carcinoma of upper urinary tract","volume":"37","author":"Lee","year":"2007","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0510","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.urolonc.2010.01.001","article-title":"Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy","volume":"30","author":"Wheat","year":"2012","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0515","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00345-011-0645-8","article-title":"Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients","volume":"29","author":"Otto","year":"2011","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0520","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.urology.2010.09.032","article-title":"Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma","volume":"77","author":"Youssef","year":"2011","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0525","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.urology.2004.11.001","article-title":"Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract","volume":"65","author":"Hong","year":"2005","journal-title":"Urology"},{"issue":"8","key":"10.1016\/j.ctrv.2015.02.006_b0530","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1464-410X.2008.08135.x","article-title":"Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis","volume":"103","author":"Bolenz","year":"2009","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0535","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/01.ju.0000181801.22474.8b","article-title":"Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract","volume":"174","author":"Kikuchi","year":"2005","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0540","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.juro.2008.05.022","article-title":"The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0)","volume":"180","author":"Lin","year":"2008","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0545","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.eururo.2010.07.003","article-title":"The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center","volume":"58","author":"Favaretto","year":"2010","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.ctrv.2015.02.006_b0550","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1464-410X.2011.10461.x","article-title":"Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis","volume":"109","author":"Milojevic","year":"2012","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0555","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.eururo.2009.07.002","article-title":"Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy","volume":"57","author":"Raman","year":"2010","journal-title":"Eur Urol"},{"issue":"2 Pt 2","key":"10.1016\/j.ctrv.2015.02.006_b0560","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1111\/j.1464-410X.2011.10792.x","article-title":"Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy","volume":"110","author":"Yafi","year":"2012","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0565","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.eururo.2011.09.017","article-title":"The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy","volume":"61","author":"Chromecki","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0570","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-5347(01)65273-X","article-title":"Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma","volume":"157","author":"Keeley","year":"1997","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0575","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.juro.2010.06.106","article-title":"Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study","volume":"184","author":"Seitz","year":"2010","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0580","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00428-006-0150-4","article-title":"Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract","volume":"448","author":"Langner","year":"2006","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0585","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1464-410X.2008.08003.x","article-title":"Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients","volume":"103","author":"Remzi","year":"2009","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0590","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.urolonc.2010.07.010","article-title":"Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma","volume":"30","author":"Fritsche","year":"2012","journal-title":"Urol Oncol"},{"issue":"11","key":"10.1016\/j.ctrv.2015.02.006_b0595","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2178::AID-CNCR16>3.0.CO;2-T","article-title":"Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival","volume":"79","author":"Rey","year":"1997","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ctrv.2015.02.006_b0600","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1442-2042.2000.00230.x","article-title":"Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter","volume":"7","author":"Hashimoto","year":"2000","journal-title":"Int J Urol"},{"issue":"11","key":"10.1016\/j.ctrv.2015.02.006_b0605","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1442-2042.2005.01159.x","article-title":"The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter","volume":"12","author":"Kamijima","year":"2005","journal-title":"Int J Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0610","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.urology.2004.01.009","article-title":"Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma","volume":"63","author":"Zigeuner","year":"2004","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0615","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1464-410x.2000.00726.x","article-title":"Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter","volume":"86","author":"Kamai","year":"2000","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0620","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.urology.2010.03.070","article-title":"Expression of Ki-67 and COX-2 in patients with upper urinary tract urothelial carcinoma","volume":"76","author":"Jeon","year":"2010","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0625","first-page":"327","article-title":"Systematic review about the usefulness and prognostic value of the p53 oncoprotein and proliferation marker Ki-67 for upper urinary tract transitional cell carcinoma","volume":"57","author":"Moreno Sierra","year":"2004","journal-title":"Arch Esp Urol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0630","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0463.2008.00859.x","article-title":"EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology","volume":"116","author":"Leibl","year":"2008","journal-title":"APMIS"},{"issue":"23","key":"10.1016\/j.ctrv.2015.02.006_b0635","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1158\/1078-0432.CCR-10-0230","article-title":"Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion","volume":"16","author":"Kosaka","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0640","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00428-002-0712-z","article-title":"Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract","volume":"441","author":"Nakanishi","year":"2002","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0645","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.humpath.2008.10.010","article-title":"Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract","volume":"40","author":"Jeong","year":"2009","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.ctrv.2015.02.006_b0650","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2109::AID-CNCR32>3.0.CO;2-6","article-title":"Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract","volume":"86","author":"Nakanishi","year":"1999","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ctrv.2015.02.006_b0655","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/modpathol.3880439","article-title":"Expression of telomerase catalytic subunit (hTERT) mRNA does not predict survival in patients with transitional cell carcinoma of the upper urinary tract","volume":"14","author":"Nakanishi","year":"2001","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.ctrv.2015.02.006_b0660","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-04-1685","article-title":"Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract","volume":"11","author":"Nakanishi","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0665","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1442-2042.2007.01978.x","article-title":"Overexpression of hypoxia-inducible factor-1alpha predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract","volume":"15","author":"Ke","year":"2008","journal-title":"Int J Urol"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0670","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/jcp.2007.050666","article-title":"Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma","volume":"61","author":"Chai","year":"2008","journal-title":"J Clin Pathol"},{"issue":"28","key":"10.1016\/j.ctrv.2015.02.006_b0675","first-page":"1970","article-title":"Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof","volume":"86","author":"Zhou","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0680","first-page":"1863","article-title":"The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter","volume":"8","author":"Inoue","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0685","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.urology.2003.09.035","article-title":"Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival","volume":"63","author":"Miyata","year":"2004","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0690","first-page":"2439","article-title":"HER-2\/AKT expression in upper urinary tract urothelial carcinoma: prognostic implications","volume":"30","author":"Izquierdo","year":"2010","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0695","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.eururo.2007.10.016","article-title":"Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage","volume":"54","author":"Caprodossi","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctrv.2015.02.006_b0700","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/1471-2407-12-372","article-title":"Thrombospondin-1-derived 4N1K peptide expression is negatively associated with malignant aggressiveness and prognosis in urothelial carcinoma of the upper urinary tract","volume":"12","author":"Miyata","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctrv.2015.02.006_b0705","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2407-6-140","article-title":"Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components","volume":"6","author":"Ioachim","year":"2006","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0710","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1464-410X.2006.06158.x","article-title":"Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract","volume":"97","author":"Ohtsuka","year":"2006","journal-title":"BJU Int"},{"issue":"15","key":"10.1016\/j.ctrv.2015.02.006_b0715","first-page":"5501","article-title":"Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder","volume":"9","author":"Koga","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0720","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/(SICI)1097-0215(19970822)74:4<446::AID-IJC15>3.0.CO;2-7","article-title":"E-cadherin expression in upper-urinary-tract carcinoma","volume":"74","author":"Nakanishi","year":"1997","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0725","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1590\/S1677-55382012000400005","article-title":"Immune expression of E-cadherin and alpha, beta and gamma-Catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas","volume":"38","author":"Reis","year":"2012","journal-title":"Int Braz J Urol"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0730","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.eururo.2005.07.005","article-title":"Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma","volume":"48","author":"Fromont","year":"2005","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0735","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1464-410X.2008.08292.x","article-title":"Adhesion molecules alpha, beta and gamma-catenin as prognostic factors of tumour progression in upper urinary tract urothelial tumours: the role of AKT-P\/GSK-3beta\/beta-catenin pathway","volume":"104","author":"Izquierdo","year":"2009","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0740","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.bjc.6605835","article-title":"Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract","volume":"103","author":"Wu","year":"2010","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0745","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00428-006-0316-0","article-title":"CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression","volume":"450","author":"Winkler","year":"2007","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0750","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1464-410X.2007.06934.x","article-title":"The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically","volume":"100","author":"Saito","year":"2007","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0755","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1442-2042.2012.03121.x","article-title":"Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes","volume":"20","author":"Saito","year":"2013","journal-title":"Int J Urol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0760","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1442-2042.2010.02671.x","article-title":"Prognostic significance of preoperative serum CYFRA 21-1 in patients with upper urinary tract urothelial carcinoma","volume":"18","author":"Suyama","year":"2011","journal-title":"Int J Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0765","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.urology.2005.01.019","article-title":"Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma","volume":"65","author":"Roupret","year":"2005","journal-title":"Urology"},{"issue":"13","key":"10.1016\/j.ctrv.2015.02.006_b0770","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.2005.03.163","article-title":"Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma","volume":"23","author":"Catto","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2015.02.006_b0775","first-page":"244","article-title":"Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract","volume":"90","author":"Burger","year":"2006","journal-title":"Verh Dtsch Ges Pathol"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0780","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2008.06.013","article-title":"FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours","volume":"55","author":"van Oers","year":"2009","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0785","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.eururo.2006.08.045","article-title":"Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma","volume":"51","author":"Marin-Aguilera","year":"2007","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0790","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.eururo.2010.04.026","article-title":"Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours","volume":"58","author":"Mian","year":"2010","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0795","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.urolonc.2010.08.006","article-title":"The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer","volume":"30","author":"Fernandez","year":"2012","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0800","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.juro.2012.08.017","article-title":"Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients","volume":"188","author":"Picozzi","year":"2012","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ctrv.2015.02.006_b0805","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bju.12014","article-title":"Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes","volume":"112","author":"Rink","year":"2013","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ctrv.2015.02.006_b0810","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s12032-013-0640-6","article-title":"Age-specific effect of gender on upper tract urothelial carcinoma outcomes","volume":"30","author":"Liu","year":"2013","journal-title":"Med Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0815","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.urolonc.2009.11.007","article-title":"Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?","volume":"29","author":"Raman","year":"2011","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0820","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.juro.2010.03.030","article-title":"Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma","volume":"184","author":"Brien","year":"2010","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0825","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.urology.2007.06.1106","article-title":"Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma","volume":"70","author":"Cho","year":"2007","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0830","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.urolonc.2008.10.023","article-title":"Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?","volume":"29","author":"Ng","year":"2011","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0835","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1464-410X.2006.06519.x","article-title":"Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location","volume":"98","author":"Zigeuner","year":"2006","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ctrv.2015.02.006_b0840","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.urology.2007.03.051","article-title":"Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy","volume":"70","author":"Brown","year":"2007","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0845","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-5347(05)67970-0","article-title":"Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach","volume":"163","author":"Guarnizo","year":"2000","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ctrv.2015.02.006_b0850","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.juro.2007.08.131","article-title":"Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance","volume":"179","author":"Tran","year":"2008","journal-title":"J Urol"},{"issue":"16","key":"10.1016\/j.ctrv.2015.02.006_b0855","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/cncr.25122","article-title":"Highly predictive survival nomogram after upper urinary tract urothelial carcinoma","volume":"116","author":"Jeldres","year":"2010","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0860","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/bjc.2012.64","article-title":"Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram","volume":"106","author":"Yates","year":"2012","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ctrv.2015.02.006_b0865","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","article-title":"Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"61","author":"Cha","year":"2012","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctrv.2015.02.006_b0870","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.urolonc.2011.07.011","article-title":"Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma","volume":"31","author":"Messer","year":"2013","journal-title":"Urol Oncol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737215000274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737215000274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T22:01:08Z","timestamp":1566338468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737215000274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":174,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0305737215000274"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2015.02.006","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A contemporary review of management and prognostic factors of upper tract urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}